ong-Term Tremor Evaluation In Patients Receiving Incisionless Surgery with FUS

Recruiting

Conditions: G25.0
G20.9
Essential tremor

Registration Number: DRKS00016695

Lead Sponsor: niversitätsklinik Bonn: NeuroRadiologische Klinik, Radiologische Klinik, Klinik für Neurologie, Neurochirurgische Klinik Hauptverantwortliche der Studie: Prof. Dr. U. Wüllner, Prof. Dr. H. Vatter, Prof. Dr. H. Boecker, Prof. Dr. A. Radbruch

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 200

Inclusion Criteria

both sexes, Age 18 and older, patients with a proven movement disorder of the head (tremor, dystonia) or motoric restlessness, who can tolerate the clinically established MRgFUS therapy and are suitable for it
Ability of the patient to give informed consent, MRI capability according to the safety standards defined for the study clinic

Exclusion Criteria

Deviation from inclusion criteria, withdrawal of consent, patients who do not meet the criteria for a safe MRI, or who would otherwise be classified as having a high risk according to the general hospital MRI check result, patients included in the screening questionnaire have found MRI or study participation to be a burden.

Study & Design

Study Type: observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Observational study without classic endpoint.<br>Aims:<br>1. Identify optimal thalamic therapy point in the brain for future MRgFUS therapies<br>2. to individualize the therapy to the individual patient (optimization of the therapy point, the delivered amount of energy, the point size related to the tremor shape / diagnosis)<br>3. Generate long-term findings regarding the outcome according to MRgFUS.

Secondary Outcome Measures